ClinicalTrials.gov
public full text
Public Domain
Effect of Molecular Hydrogen in Patients With NAFLD
Molecular hydrogen H2 acts as antioxidant which selectively reduces cytotoxic harmful reactive oxygen species ROS and concomitantly acts as biological messenger, which mediates several signaling pathways that play cytoprotective role in many human diseases. Due to their small size and high permeability, H2 is easily transportable into subcellular structures as mitochondria.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- NRF2 signaling cascade in amyotrophic lateral sclerosis: bridging the gap between promise and reality#1120590
- OXIDATIVE STRESS, INFLAMMATION, AND CHRONIC DISEASES: THERAPEUTIC POTENTIAL OF NATURAL PRODUCTS#210167
- Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide.#7045
- Reduced Sulfur Diet in Ulcerative Colitis Patients#836647
- Effect of N-acetylcysteine as Adjunct Therapy on the Clinical Outcome of Neonatal Sepsis#1151364
Record · ID 871709
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive